GlobeNewswire Clinical StudiesOriginal article
KORTUC Achieves Target Enrollment in Registrational Breast Cancer Trial as Three Global Clinical Programs Advance
Trial StartK-BOOSTPositive
AI Analysis
Summary
KORTUC achieved target enrollment of 184 patients in its registrational breast cancer trial and is advancing cervical cancer studies with UC San Diego and a newly authorized K-BOOST rectal cancer program.
Clinical Trial Data
Phase
registrational
Patients
184
Importance:6/10
Sentiment:
0.70
breast cancercervical cancerrectal cancerclinical trialenrollmentregistrational
Read the original article
Published by GlobeNewswire Clinical Studies on September 15, 2026 1:00 PM
